Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system

Appetite

Volumn 7, Issue , 1986, Pages 15-38

  Garattini, S ^a   Mennini, T ^a   Bendotti, C ^a   Invernizzi, R ^a   Samanin, R ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1 (2 CYANOETHYL) 1,2,3,6 TETRAHYDRO 4 (3 TRIFLUOROMETHYLPHENYL)PYRIDINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 AMINO 1 (6 CHLORO 2 PYRIDYL)PIPERIDINE; APOMORPHINE; BICUCULLINE; BUTACLAMOL; CLONIDINE; CYPROHEPTADINE; DESIPRAMINE; DEXAMPHETAMINE; FENFLURAMINE; IMIPRAMINE; INDALPINE; METERGOLINE; NORFENFLURAMINE; PENFLURIDOL; PHENTOLAMINE; PIZOTIFEN; PROPRANOLOL; QUIPAZINE; RADIOISOTOPE; SEROTONIN; SEROTONIN H 3; UNCLASSIFIED DRUG;

CENTRAL NERVOUS SYSTEM; DRUG MECHANISM; DRUG THERAPY; HUMAN; OBESITY; ORAL DRUG ADMINISTRATION; REVIEW; SHORT SURVEY; THERAPY;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ACETYLCHOLINE; ANIMALS; APPETITE; APPETITE DEPRESSANTS; BRAIN; BRAIN CHEMISTRY; DOPAMINE; ENDORPHINS; FEEDING BEHAVIOR; FENFLURAMINE; GAMMA-AMINOBUTYRIC ACID; HYDROXYINDOLEACETIC ACID; NEURAL PATHWAYS; NOREPINEPHRINE; PIPERAZINES; PYRIDINES; QUIPAZINE; RATS; SEROTONIN; SEROTONIN ANTAGONISTS; TETRAHYDRONAPHTHALENES;

EID: 0022474078     PISSN: 01956663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6663(86)80050-2     Document Type: Article

References (102)

1. Simultaneous determination of DA, NA, 5HT and their metabolites in several rat brain areas by HPLC with electrochemical detection
2. Lisuride, LY-141865, and 8-OH-DPAT facilitate male rat sexual behavior via a non-dopaminergic. mechanism
3. Diminished amphetamine anorexia and enhanced fenfluramine anorexia after midbrain. 6-hydroxydopamine
4. Anorectics: Lack of cross tolerance among serotonergic drugs and sensitization of amphetamine's effect
5. Do enkephalin systems mediated drive reduction?
6. Pharmacological characterization of CM 57227, a new anorexigenic agent
7. 6-hydroxydopamine
8. Pharmacological manipulation of feeding behavior: Possible influences of serotonin and dopamine on food intake
9. The roles of brain noradrenaline and dopamine in the anorectic activity of diethylproprion in rats. A comparison with. D-amphetamine
10. D-Fenfluramine and d-norfenfluramine reduce food intake by acting on different serotonin mechanisms in the rat. brain
11. Paradoxical decrease of brain 5-HT turnover by metergoline, a central 5-HT receptor. blocker
12. 3H] dopamine binding associated with dopamine receptors in calf brain. membranes
13. 5,6-Dihydroxytryptamine: Suppression of the anorexigenic action of fenfluramine
14. Fenfluramine and brain. serotonin
15. Increase in rat striatal acetylcholine content by d-fenfluramine, a serotonin releaser
16. Differential effects of the isomers of fenfluramine and norfenfluramine on rat striatal acetylcholine content
17. Comparison of the effects of the stereoisomers of fenfluramine on the acetylcholine content of rat striatum, hippocampus and nucleus. accumbens
18. Action of fenfluramine on monoamine stores of rat tissues
19. The role of the raphé and extrapyramidal nuclei in the stereotyped and circling responses to quipazine
20. Effects of D- and L-fenfluramine on striatal homovanillic acid concentrations in rats after pharmacological manipulation of brain serotonin
21. The serotonin agonist 8-OH-DPAT elicits feeding in non-deprived rats
22. Fenfluramine anorexia: A peripheral locus of action
23. Interactions between serotonergic and enkephalinergic neurons in rat striatum and hypothalamus
24. Fenfluramine long-term administration and brain serotonin
25. Modification du taux de Serotonine cérébrale chez le rat par les trifluorométhylphenyl-2-éthyl aminopropane (fenfluramine 768 S)
26. Anorectic properties of a new long acting serotonin uptake inhibitor
27. Feeding and drinking deficits after 6-hydroxydopamine administration in the rat: Similarities to the lateral hypothalamic syndrome
28. Decreased accumulation of brain 5-hydroxytryptophan after decarboxylase inhibition in rats treated with fenfluramine, norfenfluramine or p- chloroamphetamine
29. Lack of cytotoxic effect of fenfluramine
30. Anorectic drugs and brain neurotransmitters
31. Appetite suppressant drugs: Past, present and future
32. Recent advances in the pharmacology of anorectic agents
33. 6-Hydroxydopamine, a tool to study distribution of drugs in the catecholaminergic system
34. Biochemical pharmacology of the anorectic drug fenfluramine: A review
35. Effect of thymoleptics on fenfluramine-induced depletion of brain serotonin in rats
36. Effects of Lilly 110140, a specific inhibitor of 5-hydroxy-tryptamine uptake, on food intake and 5-hydroxytryptophan-induced anorexia. Evidence for serotoninergic inhibition of feeding
37. 3H-PAT
38. 3H-PAT in the rat CNS
39. Stimulation of food intake by muscimol and beta endorphin
40. Possible involvement of endogenous opiates in the tolerance to the anorectic effect of fenfluramine
41. Serotonin receptors in the brain
42. The effects of quipazine on 5-HT metabolism in the rat brain
43. 5-enkephalin and β-endorphin hypothalamic content in rats receiving anorectic drugs: Differences between D- fenfluramine and D-amphetamine
44. Accumulation of hypothalamic endorphins after repeated injections of anorectics which release serotonin
45. Fenfluramine: Evidence for a neurotoxic action on midbrain and a long-term depletion of serotonin
46. Fenfluramine: Cumulative neurotoxicity after chronic treatment with low dosages in the rat
47. 3H]-( + )- amphetamine binding sites in the rat central nervous system
48. G. 8-Hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity
49. Differential effects of p-chlorophenylalanine and 5,7-dihydroxytryptamine on feeding in rats
50. Effects of m-chlorophenylpiperazine on receptor binding and brain metabolism of monoamines in rats
51. Is receptor activation involved in the mechanism by which (+)-fenfluramine and ( +)-norfenfluramine deplete 5-hydroxy-tryptamine in the rat brain?
52. GABA and hypothalamic feeding systems. I. Topographic analysis of the effects of microinjections of muscimol
53. Coincidence of blockade of synaptosomal 5-hydroxytryptamine uptake and decrease in tryptophan hydroxylase activity: Effects of fenfluramine
54. Simultaneous determination of noradrenaline and 3-methoxy-4-hydroxy-phenylethyleneglycol sulfate in discrete brain regions of the rat
55. Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus
56. Simultaneous measurement of tyrosine, tryptophan and related monoamines for the determination of neurotransmitter turnover in discrete rat brain regions by liquid chromatography with electrochemical detection
57. Pharmacology and biochemistry of fenfluramine
58. Tolerance to anorectic drugs: Pharmacological or artifactual
59. Evidence for carrier-mediated efflux of dopamine from corpus striatum
60. 3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine
61. Carrier-mediated and carrier-independent release of serotonin from isolated central nerve endings
62. Effects of narcotic analgesics on the uptake and release of 5-hydroxytryptamine in rat synaptosomal preparations
63. Adaptive changes in central serotonin receptors after long-term drug treatment in rats
64. Evidence of the existence of two different intraneuronal pools from which pharmacological agents can release serotonin
65. Biochemical and functional studies on tolerance to anorectic activity of d-fenfluramine in comparison with d-amphetamine
66. Changes in serotonin, but not catecholamine, receptor binding in the brain of morphine-dependent rats
67. Increased number of brain benzodiazepine receptors after in-vivo administration of estazolam to rats
68. Anorectic effect of fenfluramine isomers and metabolites: Relationship between brain levels and in vitro potencies on serotonergic mechanisms
69. 3H]5-HT recognition site
70. Amphetamine analogues and brain amines
71. Degenerative effects of various neurotoxic indoleamines on central monoamine neurons
72. (+)-Amphetamine binding to rat hypothalamus: Relation to anorectic potency of phenylethylamines
73. Fenfluramine: A review of its pharmacological properties and therapeutic efficacy in obesity
74. A rapid and simple method for the determination of picogram levels of serotonin in brain tissue using liquid chromatography with electrochemical detection
75. Two new agents that affect eating through an action on monoaminergic systems
76. Different behavioral mechanisms underlie tolerance to the anorectic effects of fenfluramine and quipazine
77. Differences among ‘serotonergic’ anorectics in a cross-tolerance paradigm: Do they all act on serotonin systems?
78. Drugs affecting serotonin and feeding
79. The serotoninergic system in the brain and its possible functional connections with other aminergic systems
80. Neuropharmacology of feeding
81. The effects of selective lesioning of brain serotonin or catecholamine containing neurones on the anorectic activity of fenfluramine and amphetamine
82. Specificity of serotoninergic involvement in the decrease of food intake induced by quipazine in the rat
83. Differential role of brain monoamines in the activity of anorectic drugs
84. m- Chlorophenylpiperazine: A central serotonin agonist causing powerful anorexia in rats
85. Further studies on the mechanism of serotonin-dependent anorexia in rats
86. Evidence that it is possible to cause anorexia by increasing release and/or directly stimulating postsynaptic serotonin receptors in the brain
87. 3H] serotonin binding and functional studies in the rat
88. Long-term effects of p-chloroamphetamine and related drugs on central serotonergic mechanisms
89. Decrease in [3H]-serotonin binding in rat brain produced by the repeated administration of either monoamine oxidase inhibitors or centrally acting serotonin agonists
90. Modulation of receptor mechanisms in the CNS: Hyper- and hyposensitivity to catecholamines
91. Localisation of tricyclic antidepressant binding sites on serotonin nerve terminals
92. The effect of cyproheptadine on hunger, calorie intake and body weight in man
93. Effect of zimelidine, a new antidepressant, on appetite and body weight
94. Lack of morphological changes in the neurons of the B-9 group in rats treated with fenfluramine
95. Interaction of metergoline with striatal dopamine system
96. Pizotifen (BC-105): A review of its pharmacological properties and its therapeutic efficacy in vascular headaches
97. Species differences in the rate of disappearance of fenfluramine and its effects on brain serotonin neurons
98. Recovery of function following brain damage: Implications for motivated ingestive behaviors
99. Evidence of the modulatory role of serotonin in acetylcholine release from striatal intraneurons
100. Orexigenic effects of pizotifen and cyproheptadine in cats
101. A comparison of the effects of fenfluramine and amphetamine on uptake, release and catabolism of norepinephrine in rat brain